OnKure Therapeutics, Inc. (OKUR) Stock

Healthcare · Biotechnology · Member of Other US Stocks

OnKure Therapeutics, Inc. (OKUR) closed at USD 2.13 on 2026-10-15, a change of -33.2 % over the past year, with a market capitalization of USD 85.04M.

OnKure Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

OnKure Therapeutics, Inc. key figures

Previous close

USD 2.13 (2026-10-15)

1-year change

-33.2 %

Market cap

USD 85.04M

Enterprise value

USD -90.42M

P/E ratio (trailing)

-0.69

P/E ratio (forward)

-1.38

EPS (trailing)

-3.04

EPS (forward)

-1.53

PEG ratio

n/a

Price to book

0.49

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.02

Employees

45

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for OnKure Therapeutics, Inc. and compare it with other stocks.